Johnson Timothy B

VP (Field and Technical)MARRONE BIO INNOVATIONS INC (MBII) · full profile →Form 4 · filed Jul 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
2 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 12, 2022Grant(A)102K$0212K
Jul 12, 2022Disposed to issuer(D)212K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 12, 2022Disposed to issuer(D)1K0
Jul 12, 2022Disposed to issuer(D)6K0
Jul 12, 2022Disposed to issuer(D)200K0
Jul 12, 2022Disposed to issuer(D)200K0
Jul 12, 2022Disposed to issuer(D)50K0
Jul 12, 2022Disposed to issuer(D)155K0
Jul 12, 2022Disposed to issuer(D)33K0
Jul 12, 2022Option exercise(M)102K$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-042222) within minutes of acceptance. Every field above traces to the original document. Verify it directly: